SLEZÁKOVÁ, Silvia and Jana RUDÁ. Anticancer Activity of Artemisinin and its Derivatives. Anticancer Research. Athens: International Institute of Anticancer Research, vol. 37, No 11, p. 5995-6003. ISSN 0250-7005. doi:10.21873/anticanres.12046. 2017.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Anticancer Activity of Artemisinin and its Derivatives
Name in Czech Protinádorová aktivita artemisininu a jeho derivátů
Authors SLEZÁKOVÁ, Silvia (703 Slovakia, belonging to the institution) and Jana RUDÁ (203 Czech Republic, guarantor, belonging to the institution).
Edition Anticancer Research, Athens, International Institute of Anticancer Research, 2017, 0250-7005.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher Greece
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 1.865
RIV identification code RIV/00216224:14110/17:00098045
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.21873/anticanres.12046
UT WoS 000416143900010
Keywords in English Artemisinin; anticancer activity; Artesunate; dihydroartemisinin; review
Tags EL OK
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 20/3/2018 16:37.
Abstract
Artemisinin is an extract from the plant Artemisia annua. With its semi-synthetic derivatives, they form a group of well-known and efficacious antimalarial drugs. Recent studies have documented the potential anticancer effect of artemisinin and its derivatives (ARTs). This review summarizes results of preclinical studies, documenting mechanisms of anticancer actions of ARTs and clinical studies focused mainly on efficacy, safety and dose-ranging of ARTs as anticancer chemotherapeutics. The main mechanisms of action of ARTs is the production of reactive oxygen species, inhibition of cell cycle in G0/G1 phase, induction of apoptosis and inhibition of angiogenesis. Safety studies have shown no evident toxicity and low incidence of adverse effects. ARTs potential to inhibit growth of solid tumours suggests their application in a neoadjuvant therapy. Dihydroartemisinin and artesunate exhibit chemosensitising effects in vivo in breast, lung, pancreas and glioma cancer cells, proposing the use of ARTs also in combination anticancer therapy.
Links
MUNI/A/1063/2016, interní kód MUName: Experimentální a translační farmakologický výzkum a vývoj
Investor: Masaryk University, Category A
PrintDisplayed: 19/4/2024 21:22